Ubrolexin®

Mastitis STILL on the increase

Despite better management and a wide range of treatments the incidence of mastitis continues to rise.

With 47-65 cases per 100 cows per year¹it is now one of the most prevalent and costly diseases facing the dairy industry.²

Ubrolexin can it enhance what you do?

Ubrolexin is a powerful combination of two highly effective antibiotics – Cefalexin and Kanamycin. They work in a complementary way so that the antibiotic effect of Cefalexin is enhanced by Kanamycin and vice versa. This increases their joint ability to kill major mastitis organisms and so control disease. It’s called Synergy (1+1=3).

Ubrolexin has a broad spectrum of activity

• Ubrolexin killed major mastitis organisms in less than 9 hours *³
• Ubrolexin is effective against both gram positive and gram negative organisms ³
• Ubrolexin’s synergy means the antibiotics are more effective together than on their own 1+1=3
• Ubrolexin showed greater efficacy than a 3rd generation cephalosporin ⁴

Bacteriological cure rates for Ubrolexin⁴

Just two treatments of one tube of Ubrolexin given 24 hours apart.

Ubrolexin Synergy - ASK YOUR VET!

For more information please see the  Ubrolexin Datasheet

References

1. Bradley et al. (2007) Vet Record 160:253-258
2. Owens WE et al. (1997) J Dairy Sci 80:313-317
3. J.P. Ganiere et al. (2009) J Applied Microbiology 117-125
4. Bradley AJ, Green MJ (2009) J Dairy Sci. 92:1941-1953

*In vitro in Mueller Hinton Broth.

Advice on the use of Ubrolexin or other therapies should be sought from your veterinary surgeon. Ubrolexin contains cefalexin monohydrate and kanamycin monosulphate. Prescription only medicine. Further information is available from Boehringer Ingelheim Vetmedica, Bracknell, Berks, RG12 8YS